ClinicalTrials.gov
public full text
Public Domain
A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of single ascending intramuscular doses of MK-5720, and the safety and tolerability of multiple once-daily oral doses of MK-8189, in participants with schizophrenia. The primary study hypothesis is that the administration of MK-5720 is safe and well tolerated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)#1059708
- Safety and Efficacy of MP-214 in Patients With Schizophrenia#871436
- Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study#1174140
- A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia#993594
- Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia#1151040
Record · ID 1111428
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive